Which hedge funds own EFX? EQUIFAX INC, Q2 2026 13F holders
74 tracked hedge funds disclosed a position in EFX (EQUIFAX INC) in their Q2 2026 13F filings, worth $2.4bn in total. The largest holder by portfolio weight is Theleme Partners LLP at 5.4% of its book. 28 opened a new position this quarter: Egerton Capital (UK) LLP, Aquatic Capital Management LLC, Vulcan Value Partners, HighVista Strategies LLC. 13 exited: Cantillon Capital Management, Findlay Park Partners, Dockside LLC.
- 74
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 28
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 13
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $376m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $418m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $2.4bn
- Combined value Sum of the holders' reported positions in the security.
- 6.0%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Cantillon Capital Management | 2.1% | $323m |
| Findlay Park Partners | 1.0% | $71.1m |
| Dockside LLC | 0.2% | $920k |
| Landscape Capital Management, L.L.C. | 0.2% | $3.2m |
| Freestone Grove Partners LP | 0.1% | $15.4m |
| Numerai GP LLC | 0.08% | $758k |
| Edgestream Partners, L.P. | 0.07% | $2.2m |
| Patton Fund Management, Inc. | 0.05% | $281k |
| Prelude Capital Management, LLC | 0.02% | $294k |
| Twin Tree Management, LP | 0.02% | $97.1k |
| Boothbay Fund Management, LLC | 0.01% | $438k |
| Weiss Asset Management LP | 0.01% | $462k |
| Parallax Volatility Advisers, L.P. | 0.0% | $180 |
Ownership over time
Who discovered EFX first? Beta
| Harbor Spring Capital, LLC high conviction | Q3 2016 | +5.0 pts |
| Findlay Park Partners | Q2 2013 | +2.0 pts |
| Eminence Capital, LP | Q3 2009 | +1.8 pts |
| Sandler Capital Management | Q3 2015 | +0.7 pts |
| Tudor Investment Corp ET AL | Q1 2014 | +0.2 pts |
| PFM Health Sciences, LP | Q1 2015 | +0.2 pts |
| Axon Capital LP high conviction | Q3 2017 | −0.4 pts |
| Price Capital Management, Inc. | Q3 2015 | – |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.